Search Results

301 - 325 of 81651
TitleWireDateTime
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors Globe Newswire 05/21 17:21
SPORTRADAR LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sportradar Group AG and Encourages Investors to Contact the Firm Globe Newswire 05/21 17:13
Trump eases refrigerant rule in a bid to address surging grocery costs AP Online 05/21 17:09
The Trump administration expands its use of AI in the hunt for healthcare fraud AP Online 05/21 17:09
US stocks edge higher following the latest U-turn for oil prices AP Online 05/21 17:08
Equus Announces First Quarter Net Asset Value Globe Newswire 05/21 17:07
ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES Globe Newswire 05/21 17:06
Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season Globe Newswire 05/21 17:06
Woman at center of sprawling Minnesota fraud gets nearly 42-year prison sentence AP Online 05/21 17:05
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology Globe Newswire 05/21 17:05
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis Globe Newswire 05/21 17:01
Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models Globe Newswire 05/21 17:01
ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX Globe Newswire 05/21 17:01
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit Globe Newswire 05/21 17:00
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting Globe Newswire 05/21 17:00
Navient declares second quarter common stock dividend Globe Newswire 05/21 17:00
Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC Globe Newswire 05/21 17:00
Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash Globe Newswire 05/21 17:00
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC Globe Newswire 05/21 17:00
ATRARA (NASDAQ:ATRA) DEADLINE MAY 22nd: Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action Lawsuit Globe Newswire 05/21 16:52
The Math Underlying the Success of Tort Reforms – Florida Property Insurance and Beyond Globe Newswire 05/21 16:45
CVB Financial Corp. Names George A. Borba Jr. Chairman of the Board; Prior Chairman Hal W. Oswalt Transitions to Vice Chairman Globe Newswire 05/21 16:45
AMSC to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 27, 2026 Globe Newswire 05/21 16:45
ROSEN, THE FIRST FILING FIRM, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET  Globe Newswire 05/21 16:35
Kadant Authorizes Share Repurchase Globe Newswire 05/21 16:32
301 - 325 of 81651

News, Photo and Web Search

Search News by Ticker